REVERSE SPLIT 1:1000
02/26/2016 posted in Press Releases
Chino Hills, CA – February 26, 2016) – On February 2, 2016, SOHM, Inc. (PINKSHEETS: SHMN), a manufacturer of generic Pharmaceutical, Nutraceutical and Cosmeceutical drug products, filed Articles of Amendment with the Nevada SOS whereby it authorized the decrease of the Company’s authorized shares of common stock from 2 billion shares to 1 billion shares, par value $0.0001, with no other changers to any other class of the Company’s capital stock.
At the same time, the Company conducted a reverse split of all of its issued and outstanding shares of common stock at a ratio of one-for one thousand shares (1:1,000). As a result of such reverse split, the number of issued and outstanding shares will decrease from 1,546,636,478 to 1,546,636 shares.
On February 10, 2016, the Company filed an Issuer Company-Related Action Notification Form with FINRA requesting the reverse split at a ratio of one-for-one thousand shares be effected in the market upon approval.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India. Although SOHM’s generic pharmaceuticals are exported globally and will be introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
This press release contains many forward-looking statements such as “project,” “plan,” “can,” etc. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact: